Correction: The increasing incidence of visceral leishmaniasis relapse in South Sudan: A retrospective analysis of field patient data from 2001-2018.

Correction: The increasing incidence of visceral leishmaniasis relapse in South Sudan: A retrospective analysis of field patient data from 2001-2018.

[This corrects the article DOI: 10.1371/journal.pntd.0010696.].

Bibliographic Details
Main Authors:	Gabriel Naylor-Leyland, Simon M Collin, Francis Gatluak, Margriet den Boer, Fabiana Alves, Abdul Wasay Mullahzada, Koert Ritmeijer
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2024-02-01
Series:	PLoS Neglected Tropical Diseases
Online Access:	https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0011952&type=printable

Similar Items

The increasing incidence of visceral leishmaniasis relapse in South Sudan: A retrospective analysis of field patient data from 2001-2018.
by: Gabriel Naylor-Leyland, et al.
Published: (2022-08-01)

A clinical severity scoring system for visceral leishmaniasis in immunocompetent patients in South Sudan.
by: Suzette S Kämink, et al.
Published: (2017-10-01)

Visceral leishmaniasis relapse in Southern Sudan (1999-2007): a retrospective study of risk factors and trends.
by: Stanislaw Gorski, et al.
Published: (2010-01-01)

Outcomes of visceral leishmaniasis in pregnancy: A retrospective cohort study from South Sudan.
by: Judith E Pekelharing, et al.
Published: (2020-01-01)

A Comparison of the Effectiveness of Sodium Stibogluconate Monotherapy to Sodium Stibogluconate and Paromomycin Combination for the Treatment of Severe Post Kala Azar Dermal Leishmaniasis in South Sudan - A Retrospective Cohort Study.
by: Charles Abongomera, et al.
Published: (2016-01-01)

Correction: The increasing incidence of visceral leishmaniasis relapse in South Sudan: A retrospective analysis of field patient data from 2001–2018
Published: (2024-02-01)

Determinants of Visceral Leishmaniasis: A Case-Control Study in Gedaref State, Sudan.
by: Fabienne Nackers, et al.
Published: (2015-11-01)

Control of visceral leishmaniasis in East Africa: fragile progress, new threats
by: Margriet den Boer, et al.
Published: (2021-08-01)

Visceral Leishmaniasis and HIV coinfection in East Africa.
by: Ermias Diro, et al.
Published: (2014-06-01)

The safety and efficacy of miltefosine in the long-term treatment of post-kala-azar dermal leishmaniasis in South Asia - A review and meta-analysis.
by: Joyce Pijpers, et al.
Published: (2019-02-01)

Burden of visceral leishmaniasis in villages of eastern Gedaref State, Sudan: an exhaustive cross-sectional survey.
by: Yolanda Kathrin Mueller, et al.
Published: (2012-01-01)

Anticipating visceral leishmaniasis epidemics due to the conflict in Northern Ethiopia.
by: Carl Boodman, et al.
Published: (2023-03-01)

Anticipating visceral leishmaniasis epidemics due to the conflict in Northern Ethiopia
by: Carl Boodman, et al.
Published: (2023-03-01)

Visceral leishmaniasis as an AIDS defining condition: towards consistency across WHO guidelines.
by: Johan van Griensven, et al.
Published: (2014-07-01)

Eco-epidemiology of visceral leishmaniasis in Ethiopia
by: Endalamaw Gadisa, et al.
Published: (2015-07-01)

Barriers to access to visceral leishmaniasis diagnosis and care among seasonal mobile workers in Western Tigray, Northern Ethiopia: A qualitative study.
by: Rebecca Marie Coulborn, et al.
Published: (2018-11-01)

Effectiveness and safety of short course liposomal amphotericin B (AmBisome) as first line treatment for visceral leishmaniasis in Bangladesh.
by: Emiliano Lucero, et al.
Published: (2015-04-01)

Visceral Leishmaniasis in pregnancy and vertical transmission: A systematic literature review on the therapeutic orphans.
by: Prabin Dahal, et al.
Published: (2021-08-01)

Epidemiological and molecular investigation of resurgent cutaneous leishmaniasis in Sudan
by: Sarah Collis, et al.
Published: (2019-11-01)

Use of Pentamidine As Secondary Prophylaxis to Prevent Visceral Leishmaniasis Relapse in HIV Infected Patients, the First Twelve Months of a Prospective Cohort Study.
by: Ermias Diro, et al.
Published: (2015-01-01)

Leishmania Antigenuria to Predict Initial Treatment Failure and Relapse in Visceral Leishmaniasis/HIV Coinfected Patients: An Exploratory Study Nested Within a Clinical Trial in Ethiopia
by: Johan van Griensven, et al.
Published: (2018-03-01)

Relationship of serum antileishmanial antibody with development of visceral leishmaniasis, post-kala-azar dermal leishmaniasis and visceral leishmaniasis relapse
by: Mondal, D, et al.
Published: (2019)

Relationship of Serum Antileishmanial Antibody With Development of Visceral Leishmaniasis, Post-kala-azar Dermal Leishmaniasis and Visceral Leishmaniasis Relapse
by: Dinesh Mondal, et al.
Published: (2019-10-01)

Risk factors of inpatients mortality of visceral leishmaniasis, Khartoum State, Sudan
by: Omaima Abdel Majeed Mohamed Salih, et al.
Published: (2020-01-01)

Hypokalaemia-induced rhabdomyolysis after treatment of post-Kala-azar dermal Leishmaniasis (PKDL) with high-dose AmBisome in Bangladesh-a case report.
by: Ulrika Marking, et al.
Published: (2014-06-01)

Sandflies (Diptera: Psychodidae) in a focus of visceral leishmaniasis in White Nile, Sudan
by: Sally Osman Widaa, et al.
Published: (2012-06-01)

Changes in the epidemiology of visceral leishmaniasis in Brazil from 2001 to 2014
by: Lisiane Lappe dos Reis, et al.

Outdoor Residual Insecticide Spraying (ODRS), a New Approach for the Control of the Exophilic Vectors of Human Visceral Leishmaniasis: Phlebotomus orientalis in East Africa.
by: Dia-Eldin A Elnaiem, et al.
Published: (2020-10-01)

Spatio-temporal modeling of visceral leishmaniasis in Midwest Brazil: An ecological study of 18-years data (2001-2018).
by: Everton Falcão de Oliveira, et al.
Published: (2020-01-01)

Spatio-temporal modeling of visceral leishmaniasis in Midwest Brazil: An ecological study of 18-years data (2001–2018)
by: Everton Falcão de Oliveira, et al.
Published: (2020-01-01)

Fractional-order modeling of visceral leishmaniasis disease transmission dynamics : strategies in eastern Sudan
by: Ghada A. Ahmed
Published: (2023-11-01)

Host, parasite and drug determinants of clinical outcomes following treatment of visceral leishmaniasis: a protocol for individual participant data meta-analysis
by: James Wilson, et al.
Published: (2023-10-01)

Haematological dynamics following treatment of visceral leishmaniasis: a protocol for systematic review and individual participant data (IPD) meta-analysis
by: James Wilson, et al.
Published: (2023-12-01)

Visceral leishmaniasis relapse in HIV patients--a role for myeloid-derived suppressor cells?
by: Rafael Van den Bergh, et al.
Published: (2014-09-01)

Predictors of relapse of visceral leishmaniasis in inner São Paulo State, Brazil
by: José Cláudio Simão, et al.
Published: (2020-06-01)

Towards the elimination of visceral leishmaniasis as a public health problem in east Africa: reflections on an enhanced control strategy and a call for action
by: Jorge Alvar, MD, et al.
Published: (2021-12-01)

Severe post-kala-azar dermal leishmaniasis successfully treated with miltefosine in an Ethiopian HIV patient
by: Charles Abongomera, et al.
Published: (2019-04-01)

Paromomycin for the treatment of visceral leishmaniasis in Sudan: a randomized, open-label, dose-finding study.
by: Ahmed M Musa, et al.
Published: (2010-10-01)

Mucosal relapse of visceral leishmaniasis in a child treated with anti-TNFα
by: E. Jeziorski, et al.
Published: (2015-04-01)

Effectiveness of miltefosine in cutaneous leishmaniasis caused by Leishmania tropica in Pakistan after antimonial treatment failure or contraindications to first line therapy-A retrospective analysis.
by: Suzette Kämink, et al.
Published: (2021-01-01)